Biblio Discovery — Demo Discovery Service

4 results for "Shuling, Guo"

Showing 1–4 · 0.64 seconds · RSS

  1. Journal Article Full text

    Tmprss6 -ASO as a tool for the treatment of Polycythemia Vera mice

    Carla Casu; Alison Liu; Gianluca De Rosa et al.

    PLOS ONE, Vol. 16 No. 12 · 2021 · English · PLOS Scopus

    Polycythemia Vera (PV) is a chronic myeloproliferative neoplasm resulting from an acquired driver mutation in the JAK2 gene of hematopoietic stem and progenitor cells resulting in the overproduction of mature erythrocytes and abnormally high hematocrit, in turn leading to thromboembolic…

  2. Journal Article Full text

    Partial Hepatectomy Induced Long Noncoding RNA Inhibits Hepatocyte Proliferation during Liver Regeneration

    Lulu Huang; Sagar S. Damle; Sheri Booten et al.

    PLOS ONE, Vol. 10 No. 7 · 2015 · English · PLOS Scopus

    Liver regeneration after partial hepatectomy (PHx) is a complex and well-orchestrated biological process in which synchronized cell proliferation is induced in response to the loss of liver mass. To define long noncoding RNAs (lncRNAs) that participate in the regulation of liver regeneration, we…

  3. Journal Article Full text

    Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells

    Christoph J. Niemietz; Vanessa Sauer; Jacqueline Stella et al.

    PLOS ONE, Vol. 11 No. 9 · 2016 · English · PLOS Scopus

    Familial amyloid polyneuropathy (FAP) is caused by mutations of the transthyretin (TTR) gene, predominantly expressed in the liver. Two compounds that knockdown TTR, comprising a small interfering RNA (siRNA; ALN-TTR-02) and an antisense oligonucleotide (ASO; IONIS-TTRRx), are currently being…

  4. Journal Article Full text

    Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection

    Yuanyuan Qiao; Jesse W. Wotring; Charles J. Zhang et al.

    PLOS ONE, Vol. 18 No. 2 · 2023 · English · PLOS Scopus

    Although the COVID-19 pandemic began over three years ago, the virus responsible for the disease, SARS-CoV-2, continues to infect people across the globe. As such, there remains a critical need for development of novel therapeutics against SARS-CoV-2. One technology that has remained relatively…